Journey Medical Corporation
DERM
$7.42
$0.020.27%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 55.40M | 55.24M | 55.13M | 57.77M | 58.42M |
| Total Other Revenue | 1.00M | 1.00M | 1.00M | 0.00 | 19.26M |
| Total Revenue | 56.40M | 56.24M | 56.13M | 57.77M | 77.68M |
| Cost of Revenue | 17.25M | 18.04M | 19.25M | 19.26M | 20.41M |
| Gross Profit | 39.15M | 38.20M | 36.88M | 38.51M | 57.28M |
| SG&A Expenses | 43.91M | 42.35M | 40.20M | 39.99M | 37.23M |
| Depreciation & Amortization | 5.55M | 5.30M | 5.05M | 5.40M | 5.40M |
| Other Operating Expenses | -4.55M | -4.55M | -4.55M | -- | -- |
| Total Operating Expenses | 63.26M | 63.15M | 69.81M | 75.79M | 75.56M |
| Operating Income | -6.86M | -6.91M | -13.68M | -18.02M | 2.12M |
| Income Before Tax | -8.62M | -8.24M | -14.61M | -18.21M | 1.06M |
| Income Tax Expenses | 121.00K | 61.00K | 61.00K | 126.00K | 221.00K |
| Earnings from Continuing Operations | -8.74 | -8.30 | -14.67 | -18.34 | 0.84 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -8.74M | -8.30M | -14.67M | -18.34M | 843.00K |
| EBIT | -6.86M | -6.91M | -13.68M | -18.02M | 2.12M |
| EBITDA | -2.94M | -3.24M | -10.25M | -14.76M | 5.38M |
| EPS Basic | -0.39 | -0.39 | -0.74 | -0.93 | 0.10 |
| Normalized Basic EPS | -0.27 | -0.28 | -0.50 | -0.61 | 0.07 |
| EPS Diluted | -0.40 | -0.40 | -0.75 | -0.94 | -0.02 |
| Normalized Diluted EPS | -0.27 | -0.28 | -0.50 | -0.61 | 0.00 |
| Average Basic Shares Outstanding | 87.75M | 84.45M | 81.60M | 78.98M | 76.86M |
| Average Diluted Shares Outstanding | 87.75M | 84.45M | 81.60M | 78.98M | 79.48M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |